1 Neurovascular Thrombectomy Device Market Overview 1.1 Product Overview and Scope of Neurovascular Thrombectomy Device 1.2 Neurovascular Thrombectomy Device Segment by Type 1.2.1 Global Neurovascular Thrombectomy Device Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Mechanical/Fragmentation Thrombectomy Devices 1.2.3 Stent Retrievers 1.2.4 Basket/Brush Retrievers 1.2.5 Coil Retrievers 1.2.6 Aspiration Thrombectomy Devices 1.2.7 Rheolytic/Hydrodynamic Thrombectomy Devices 1.2.8 Ultrasonic Thrombectomy Devices 1.3 Neurovascular Thrombectomy Device Segment by Application 1.3.1 Neurovascular Thrombectomy Device Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals and Surgical Centers 1.3.3 Ambulatory Surgical Centers 1.3.4 Research Laboratories & Academic Institutes 1.3.5 Others 1.4 Global Neurovascular Thrombectomy Device Market Size Estimates and Forecasts 1.4.1 Global Neurovascular Thrombectomy Device Revenue 2016-2027 1.4.2 Global Neurovascular Thrombectomy Device Sales 2016-2027 1.4.3 Neurovascular Thrombectomy Device Market Size by Region: 2016 Versus 2021 Versus 2027 2 Neurovascular Thrombectomy Device Market Competition by Manufacturers 2.1 Global Neurovascular Thrombectomy Device Sales Market Share by Manufacturers (2016-2021) 2.2 Global Neurovascular Thrombectomy Device Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Neurovascular Thrombectomy Device Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Neurovascular Thrombectomy Device Manufacturing Sites, Area Served, Product Type 2.5 Neurovascular Thrombectomy Device Market Competitive Situation and Trends 2.5.1 Neurovascular Thrombectomy Device Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Neurovascular Thrombectomy Device Players Market Share by Revenue 2.5.3 Global Neurovascular Thrombectomy Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Neurovascular Thrombectomy Device Retrospective Market Scenario by Region 3.1 Global Neurovascular Thrombectomy Device Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Neurovascular Thrombectomy Device Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Neurovascular Thrombectomy Device Market Facts & Figures by Country 3.3.1 North America Neurovascular Thrombectomy Device Sales by Country 3.3.2 North America Neurovascular Thrombectomy Device Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Neurovascular Thrombectomy Device Market Facts & Figures by Country 3.4.1 Europe Neurovascular Thrombectomy Device Sales by Country 3.4.2 Europe Neurovascular Thrombectomy Device Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Neurovascular Thrombectomy Device Market Facts & Figures by Region 3.5.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Region 3.5.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Neurovascular Thrombectomy Device Market Facts & Figures by Country 3.6.1 Latin America Neurovascular Thrombectomy Device Sales by Country 3.6.2 Latin America Neurovascular Thrombectomy Device Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Neurovascular Thrombectomy Device Market Facts & Figures by Country 3.7.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Country 3.7.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Neurovascular Thrombectomy Device Historic Market Analysis by Type 4.1 Global Neurovascular Thrombectomy Device Sales Market Share by Type (2016-2021) 4.2 Global Neurovascular Thrombectomy Device Revenue Market Share by Type (2016-2021) 4.3 Global Neurovascular Thrombectomy Device Price by Type (2016-2021) 5 Global Neurovascular Thrombectomy Device Historic Market Analysis by Application 5.1 Global Neurovascular Thrombectomy Device Sales Market Share by Application (2016-2021) 5.2 Global Neurovascular Thrombectomy Device Revenue Market Share by Application (2016-2021) 5.3 Global Neurovascular Thrombectomy Device Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Stryker Corporation (U.S.) 6.1.1 Stryker Corporation (U.S.) Corporation Information 6.1.2 Stryker Corporation (U.S.) Description and Business Overview 6.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Stryker Corporation (U.S.) Product Portfolio 6.1.5 Stryker Corporation (U.S.) Recent Developments/Updates 6.2 Medtronic plc (Ireland) 6.2.1 Medtronic plc (Ireland) Corporation Information 6.2.2 Medtronic plc (Ireland) Description and Business Overview 6.2.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Medtronic plc (Ireland) Product Portfolio 6.2.5 Medtronic plc (Ireland) Recent Developments/Updates 6.3 Boston Scientific Corporation (U.S.) 6.3.1 Boston Scientific Corporation (U.S.) Corporation Information 6.3.2 Boston Scientific Corporation (U.S.) Description and Business Overview 6.3.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Boston Scientific Corporation (U.S.) Product Portfolio 6.3.5 Boston Scientific Corporation (U.S.) Recent Developments/Updates 6.4 Johnson & Johnson (U.S.) 6.4.1 Johnson & Johnson (U.S.) Corporation Information 6.4.2 Johnson & Johnson (U.S.) Description and Business Overview 6.4.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Johnson & Johnson (U.S.) Product Portfolio 6.4.5 Johnson & Johnson (U.S.) Recent Developments/Updates 6.5 Terumo Corporation (Japan) 6.5.1 Terumo Corporation (Japan) Corporation Information 6.5.2 Terumo Corporation (Japan) Description and Business Overview 6.5.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Terumo Corporation (Japan) Product Portfolio 6.5.5 Terumo Corporation (Japan) Recent Developments/Updates 6.6 Penumbra, Inc. (U.S.) 6.6.1 Penumbra, Inc. (U.S.) Corporation Information 6.6.2 Penumbra, Inc. (U.S.) Description and Business Overview 6.6.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Penumbra, Inc. (U.S.) Product Portfolio 6.6.5 Penumbra, Inc. (U.S.) Recent Developments/Updates 6.7 Spectranetics Corporation (U.S.) 6.6.1 Spectranetics Corporation (U.S.) Corporation Information 6.6.2 Spectranetics Corporation (U.S.) Description and Business Overview 6.6.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Spectranetics Corporation (U.S.) Product Portfolio 6.7.5 Spectranetics Corporation (U.S.) Recent Developments/Updates 6.8 Edwards Lifesciences Corporation (U.S.) 6.8.1 Edwards Lifesciences Corporation (U.S.) Corporation Information 6.8.2 Edwards Lifesciences Corporation (U.S.) Description and Business Overview 6.8.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Edwards Lifesciences Corporation (U.S.) Product Portfolio 6.8.5 Edwards Lifesciences Corporation (U.S.) Recent Developments/Updates 6.9 Argon Medical Devices, Inc. (U.S.) 6.9.1 Argon Medical Devices, Inc. (U.S.) Corporation Information 6.9.2 Argon Medical Devices, Inc. (U.S.) Description and Business Overview 6.9.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Argon Medical Devices, Inc. (U.S.) Product Portfolio 6.9.5 Argon Medical Devices, Inc. (U.S.) Recent Developments/Updates 6.10 Teleflex Incorporated (U.S.) 6.10.1 Teleflex Incorporated (U.S.) Corporation Information 6.10.2 Teleflex Incorporated (U.S.) Description and Business Overview 6.10.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Teleflex Incorporated (U.S.) Product Portfolio 6.10.5 Teleflex Incorporated (U.S.) Recent Developments/Updates 7 Neurovascular Thrombectomy Device Manufacturing Cost Analysis 7.1 Neurovascular Thrombectomy Device Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Neurovascular Thrombectomy Device 7.4 Neurovascular Thrombectomy Device Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Neurovascular Thrombectomy Device Distributors List 8.3 Neurovascular Thrombectomy Device Customers 9 Neurovascular Thrombectomy Device Market Dynamics 9.1 Neurovascular Thrombectomy Device Industry Trends 9.2 Neurovascular Thrombectomy Device Growth Drivers 9.3 Neurovascular Thrombectomy Device Market Challenges 9.4 Neurovascular Thrombectomy Device Market Restraints 10 Global Market Forecast 10.1 Neurovascular Thrombectomy Device Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Neurovascular Thrombectomy Device by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Neurovascular Thrombectomy Device by Type (2022-2027) 10.2 Neurovascular Thrombectomy Device Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Neurovascular Thrombectomy Device by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Neurovascular Thrombectomy Device by Application (2022-2027) 10.3 Neurovascular Thrombectomy Device Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Neurovascular Thrombectomy Device by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Neurovascular Thrombectomy Device by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Neurovascular Thrombectomy Device Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Neurovascular Thrombectomy Device Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Neurovascular Thrombectomy Device Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Neurovascular Thrombectomy Device Covered in This Study Table 5. Global Neurovascular Thrombectomy Device Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Neurovascular Thrombectomy Device Sales Share by Manufacturers (2016-2021) Table 7. Global Neurovascular Thrombectomy Device Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Neurovascular Thrombectomy Device Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Neurovascular Thrombectomy Device Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Neurovascular Thrombectomy Device Manufacturing Sites and Area Served Table 11. Manufacturers Neurovascular Thrombectomy Device Product Type Table 12. Global Neurovascular Thrombectomy Device Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Neurovascular Thrombectomy Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurovascular Thrombectomy Device as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Neurovascular Thrombectomy Device Sales by Region (2016-2021) & (K Units) Table 16. Global Neurovascular Thrombectomy Device Sales Market Share by Region (2016-2021) Table 17. Global Neurovascular Thrombectomy Device Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Neurovascular Thrombectomy Device Sales by Country (2016-2021) & (K Units) Table 19. North America Neurovascular Thrombectomy Device Sales Market Share by Country (2016-2021) Table 20. North America Neurovascular Thrombectomy Device Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Neurovascular Thrombectomy Device Revenue Market Share by Country (2016-2021) Table 22. Europe Neurovascular Thrombectomy Device Sales by Country (2016-2021) & (K Units) Table 23. Europe Neurovascular Thrombectomy Device Sales Market Share by Country (2016-2021) Table 24. Europe Neurovascular Thrombectomy Device Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Neurovascular Thrombectomy Device Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Neurovascular Thrombectomy Device Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Neurovascular Thrombectomy Device Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Neurovascular Thrombectomy Device Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Neurovascular Thrombectomy Device Revenue Market Share by Region (2016-2021) Table 30. Latin America Neurovascular Thrombectomy Device Sales by Country (2016-2021) & (K Units) Table 31. Latin America Neurovascular Thrombectomy Device Sales Market Share by Country (2016-2021) Table 32. Latin America Neurovascular Thrombectomy Device Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Neurovascular Thrombectomy Device Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Neurovascular Thrombectomy Device Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Neurovascular Thrombectomy Device Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Neurovascular Thrombectomy Device Revenue Market Share by Country (2016-2021) Table 38. Global Neurovascular Thrombectomy Device Sales (K Units) by Type (2016-2021) Table 39. Global Neurovascular Thrombectomy Device Sales Market Share by Type (2016-2021) Table 40. Global Neurovascular Thrombectomy Device Revenue (Million US$) by Type (2016-2021) Table 41. Global Neurovascular Thrombectomy Device Revenue Share by Type (2016-2021) Table 42. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Type (2016-2021) Table 43. Global Neurovascular Thrombectomy Device Sales (K Units) by Application (2016-2021) Table 44. Global Neurovascular Thrombectomy Device Sales Market Share by Application (2016-2021) Table 45. Global Neurovascular Thrombectomy Device Revenue (Million US$) by Application (2016-2021) Table 46. Global Neurovascular Thrombectomy Device Revenue Share by Application (2016-2021) Table 47. Global Neurovascular Thrombectomy Device Price (USD/Unit) by Application (2016-2021) Table 48. Stryker Corporation (U.S.) Corporation Information Table 49. Stryker Corporation (U.S.) Description and Business Overview Table 50. Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product Table 52. Stryker Corporation (U.S.) Recent Developments/Updates Table 53. Medtronic plc (Ireland) Corporation Information Table 54. Medtronic plc (Ireland) Description and Business Overview Table 55. Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Table 57. Medtronic plc (Ireland) Recent Developments/Updates Table 58. Boston Scientific Corporation (U.S.) Corporation Information Table 59. Boston Scientific Corporation (U.S.) Description and Business Overview Table 60. Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product Table 62. Boston Scientific Corporation (U.S.) Recent Developments/Updates Table 63. Johnson & Johnson (U.S.) Corporation Information Table 64. Johnson & Johnson (U.S.) Description and Business Overview Table 65. Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product Table 67. Johnson & Johnson (U.S.) Recent Developments/Updates Table 68. Terumo Corporation (Japan) Corporation Information Table 69. Terumo Corporation (Japan) Description and Business Overview Table 70. Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Table 72. Terumo Corporation (Japan) Recent Developments/Updates Table 73. Penumbra, Inc. (U.S.) Corporation Information Table 74. Penumbra, Inc. (U.S.) Description and Business Overview Table 75. Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product Table 77. Penumbra, Inc. (U.S.) Recent Developments/Updates Table 78. Spectranetics Corporation (U.S.) Corporation Information Table 79. Spectranetics Corporation (U.S.) Description and Business Overview Table 80. Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product Table 82. Spectranetics Corporation (U.S.) Recent Developments/Updates Table 83. Edwards Lifesciences Corporation (U.S.) Corporation Information Table 84. Edwards Lifesciences Corporation (U.S.) Description and Business Overview Table 85. Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product Table 87. Edwards Lifesciences Corporation (U.S.) Recent Developments/Updates Table 88. Argon Medical Devices, Inc. (U.S.) Corporation Information Table 89. Argon Medical Devices, Inc. (U.S.) Description and Business Overview Table 90. Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product Table 92. Argon Medical Devices, Inc. (U.S.) Recent Developments/Updates Table 93. Teleflex Incorporated (U.S.) Corporation Information Table 94. Teleflex Incorporated (U.S.) Description and Business Overview Table 95. Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product Table 97. Teleflex Incorporated (U.S.) Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Neurovascular Thrombectomy Device Distributors List Table 101. Neurovascular Thrombectomy Device Customers List Table 102. Neurovascular Thrombectomy Device Market Trends Table 103. Neurovascular Thrombectomy Device Growth Drivers Table 104. Neurovascular Thrombectomy Device Market Restraints Table 105. Global Neurovascular Thrombectomy Device Sales Forecast by Type (2022-2027) & (K Units) Table 106. Global Neurovascular Thrombectomy Device Sales Market Share Forecast by Type (2022-2027) Table 107. Global Neurovascular Thrombectomy Device Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Neurovascular Thrombectomy Device Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Neurovascular Thrombectomy Device Sales Forecast by Application (2022-2027) & (K Units) Table 110. Global Neurovascular Thrombectomy Device Sales Market Share Forecast by Application (2022-2027) Table 111. Global Neurovascular Thrombectomy Device Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Neurovascular Thrombectomy Device Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Neurovascular Thrombectomy Device Sales Forecast by Region (2022-2027) & (K Units) Table 114. Global Neurovascular Thrombectomy Device Sales Market Share Forecast by Region (2022-2027) Table 115. Global Neurovascular Thrombectomy Device Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Neurovascular Thrombectomy Device Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Neurovascular Thrombectomy Device Figure 2. Global Neurovascular Thrombectomy Device Market Share by Type in 2020 & 2027 Figure 3. Mechanical/Fragmentation Thrombectomy Devices Product Picture Figure 4. Stent Retrievers Product Picture Figure 5. Basket/Brush Retrievers Product Picture Figure 6. Coil Retrievers Product Picture Figure 7. Aspiration Thrombectomy Devices Product Picture Figure 8. Rheolytic/Hydrodynamic Thrombectomy Devices Product Picture Figure 9. Ultrasonic Thrombectomy Devices Product Picture Figure 10. Global Neurovascular Thrombectomy Device Market Share by Application in 2020 & 2027 Figure 11. Hospitals and Surgical Centers Figure 12. Ambulatory Surgical Centers Figure 13. Research Laboratories & Academic Institutes Figure 14. Others Figure 15. Global Neurovascular Thrombectomy Device Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Neurovascular Thrombectomy Device Market Size 2016-2027 (US$ Million) Figure 17. Global Neurovascular Thrombectomy Device Sales 2016-2027 (K Units) Figure 18. Global Neurovascular Thrombectomy Device Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 19. Neurovascular Thrombectomy Device Sales Share by Manufacturers in 2020 Figure 20. Global Neurovascular Thrombectomy Device Revenue Share by Manufacturers in 2020 Figure 21. The Global 5 and 10 Largest Neurovascular Thrombectomy Device Players: Market Share by Revenue in 2020 Figure 22. Neurovascular Thrombectomy Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 23. Global Neurovascular Thrombectomy Device Sales Market Share by Region (2016-2021) Figure 24. Global Neurovascular Thrombectomy Device Sales Market Share by Region in 2020 Figure 25. Global Neurovascular Thrombectomy Device Revenue Market Share by Region (2016-2021) Figure 26. Global Neurovascular Thrombectomy Device Revenue Market Share by Region in 2020 Figure 27. U.S. Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Canada Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Germany Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. France Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. U.K. Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Italy Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Russia Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. China Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Japan Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. South Korea Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. India Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Australia Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Taiwan Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Indonesia Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Thailand Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Malaysia Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Philippines Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Vietnam Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Mexico Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Brazil Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Argentina Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Turkey Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Saudi Arabia Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. U.A.E Neurovascular Thrombectomy Device Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. Sales Market Share of Neurovascular Thrombectomy Device by Type (2016-2021) Figure 52. Sales Market Share of Neurovascular Thrombectomy Device by Application (2016-2021) Figure 53. Sales Market Share of Neurovascular Thrombectomy Device by Application in 2020 Figure 54. Revenue Share of Neurovascular Thrombectomy Device by Application (2016-2021) Figure 55. Revenue Share of Neurovascular Thrombectomy Device by Application in 2020 Figure 56. Manufacturing Cost Structure of Neurovascular Thrombectomy Device Figure 57. Manufacturing Process Analysis of Neurovascular Thrombectomy Device Figure 58. Neurovascular Thrombectomy Device Industrial Chain Analysis Figure 59. Channels of Distribution Figure 60. Distributors Profiles Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Stryker Corporation (U.S.) Medtronic plc (Ireland) Boston Scientific Corporation (U.S.) Johnson & Johnson (U.S.) Terumo Corporation (Japan) Penumbra, Inc. (U.S.) Spectranetics Corporation (U.S.) Edwards Lifesciences Corporation (U.S.) Argon Medical Devices, Inc. (U.S.) Teleflex Incorporated (U.S.)